Laddar...
JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
Janus kinase inhibitors [JAKi] are a new class of small molecule drugs that modulate inflammatory pathways by blocking one or more JAK receptors, and are increasingly being used in the treatment of immune-mediated diseases. Tofacitinib, a non-selective JAKi, is now approved for moderate-to-severe ul...
Sparad:
| I publikationen: | J Crohns Colitis |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395307/ https://ncbi.nlm.nih.gov/pubmed/32006031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa017 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|